Achieve life sciences announces completion of last subject, last follow-up visit in phase 3 orca-2 trial of cytisinicline for smoking cessation

Topline orca-2 results expected in q2 2022 topline orca-2 results expected in q2 2022
ACHV Ratings Summary
ACHV Quant Ranking